Gene · 2348
Papers3,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Folate Receptor Alpha Autoantibodies in the Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) Population. | J Pers Med | 2024 | 38392599 | PubTator, text mining | PubMed |
| Noncanonical function of folate through folate receptor 1 during neural tube formation. | Nat Commun | 2024 | 38388461 | PubTator, text mining | PubMed |
| Relationship between Changes of Serum Vascular Endothelial Growth Factor and Folate Receptor-α Levels and Clinical Efficacy of Toripalimab in Patients with Bladder Cancer. | Arch Esp Urol | 2024 | 38374010 | PubTator, text mining | PubMed |
| Dexamethasone Pretreatment Potentiates a Folic Acid-Functionalized Delivery System for Enhanced Lung Cancer Therapy. | Mol Pharm | 2024 | 38346386 | PubTator, text mining | PubMed |
| Folate receptor alpha autoantibodies in the serum of patients with relapsing-remitting multiple sclerosis (RRMS). | Clin Neurol Neurosurg | 2024 | 38325038 | PubTator, text mining | PubMed |
| Research Progress of SN38 Drug Delivery System in Cancer Treatment. | Int J Nanomedicine | 2024 | 38293612 | PubTator, text mining | PubMed |
| Fluorescence visualization for cancer DETECTION: EXPERIENCE and perspectives. | Heliyon | 2024 | 38293525 | PubTator, text mining | PubMed |
| Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine. | Arch Pathol Lab Med | 2024 | 38282564 | PubTator, text mining | PubMed |
| iPSC-derived models of PACS1 syndrome reveal transcriptional and functional deficits in neuron activity. | Nat Commun | 2024 | 38280846 | PubTator, text mining | PubMed |
| Hypoxia-driven deSUMOylation of EXOSC10 promotes adaptive changes in the transcriptome profile. | Cell Mol Life Sci | 2024 | 38279024 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs. | Cancers (Basel) | 2024 | 38275888 | PubTator, text mining | PubMed |
| High-Grade Serous Ovarian Cancer-A Risk Factor Puzzle and Screening Fugitive. | Biomedicines | 2024 | 38275400 | PubTator, text mining | PubMed |
| In silico Identification of MHC Displayed Tumor Associated Peptides in Ovarian Cancer for Multi-Epitope Vaccine Construct. | Endocr Metab Immune Disord Drug Targets | 2024 | 38275062 | PubTator, text mining | PubMed |
| Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma. | Respir Res | 2024 | 38273401 | PubTator, text mining | PubMed |
| Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. | Cancer | 2024 | 38271367 | PubTator, text mining | PubMed |
| The Multifaceted Role of FUT8 in Tumorigenesis: From Pathways to Potential Clinical Applications. | Int J Mol Sci | 2024 | 38256141 | PubTator, text mining | PubMed |
| Folate Receptor Alpha-A Novel Approach to Cancer Therapy. | Int J Mol Sci | 2024 | 38256120 | PubTator, text mining | PubMed |
| Ocular Surface Side Effects of Novel Anticancer Drugs. | Cancers (Basel) | 2024 | 38254833 | PubTator, text mining | PubMed |
| Preclinical Evaluation of Novel Folate Receptor 1-Directed CAR T Cells for Ovarian Cancer. | Cancers (Basel) | 2024 | 38254822 | PubTator, text mining | PubMed |
| Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder. | J Pers Med | 2024 | 38248763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2348/papers?page=19